title: Clinical and pathological features of posttransplant lymphoproliferative disorders: influence on survival and response to treatment.
abstract: OBJECTIVE
  To review the clinical and pathological characteristics of patients with posttransplant lymphoproliferative disorders (PTLD) occurring after solid organ transplantation and determine the influence of these characteristics on response to treatment and survival.
  
  
  METHODS
  Retrospective review of 32 patients.
  
  
  RESULTS
  Overall five-year survival was 59%. Forty-five percent of patients diagnosed within the first year after transplant had advanced disease. Characteristics that were associated with poorer survival were diagnosis within the first year posttransplant, monoclonal tumors and presentation with an infectious mononucleosis-like syndrome. Six of eight patients treated with surgery are alive and disease-free.
  
  
  CONCLUSIONS
  Patients with PTLD can achieve long-term survival. Surgery can play an important role in selected patients. Characteristics that may be associated with poorer survival are diagnosis within the first year after transplant, presence of a monoclonal tumor or an infectious mononucleosis-like presentation.
authors.affiliation: Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198-7680, USA. rhauke@unmc.edu
authors.forename: R
authors.initials: R
authors.lastname: Hauke
authors.forename: B
authors.initials: B
authors.lastname: Smir
authors.forename: T
authors.initials: T
authors.lastname: Greiner
authors.forename: P
authors.initials: P
authors.lastname: Bierman
authors.forename: S
authors.initials: S
authors.lastname: Tarantolo
authors.forename: J
authors.initials: J
authors.lastname: Anderson
authors.forename: B
authors.initials: B
authors.lastname: Shaw
authors.forename: J
authors.initials: J
authors.lastname: Armitage
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000209:etiology / Q000473:pathology; D006801:Humans; D007223:Infant; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016377:Organ Transplantation / Q000009:adverse effects*; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis